Autologous Lymphokine-Activated Killer Cell Therapy of Epstein-Barr Virus-Positive and -Negative Lymphoproliferative Disorders Arising in Organ Transplant Recipients1
Transplantation - United States
doi 10.1097/00007890-199705150-00002
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 1997
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)